Reliability, validity and responsiveness of the Mandarin (Simplified) Chinese version of the EORTC QLQ-OH45 among cancer patients
Author:
Affiliation:
1. Chengdu University of Traditional Chinese Medicine; Chengdu China
Publisher
Wiley
Subject
Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12987/fullpdf
Reference38 articles.
1. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology;Aaronson;Journal of the National Cancer Institute,1993
2. Sensitivity to change of rheumatoid arthritis clinical trial outcome measures;Anderson;Journal of Rheumatology,1993
3. Reliability and validity of amharic version of EORTC QLQ-C 30 questionnaire among gynecological cancer patients in Ethiopia;Ayana;PLoS ONE,2016
4. Current practice and knowledge of oral care for cancer patients: A survey of supportive health care providers;Barker;Supportive Care in Cancer,2005
5. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30;Borghede;Quality of Life Research,1996
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka;BMC Oral Health;2022-08-19
2. Validity and reliability of the Chinese version of the Patient-Reported Outcomes Measurement Information System adult profile-57 (PROMIS-57);Health and Quality of Life Outcomes;2022-06-15
3. Temporal stability of quality of life assessments in cancer patients;Scientific Reports;2021-03-04
4. Reminiscence therapy‐based care program relieves anxiety, depression, and improves quality of life in post‐operational non‐small cell lung cancer patients;The Clinical Respiratory Journal;2021-01-28
5. Efficacy and safety of Jianpishengsui for chemotherapy-related fatigue in patients with non-small cell lung cancer: study protocol for a randomized placebo-controlled clinical trial;Trials;2020-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3